Charlie's Holdings, Inc.
CHUCOTCCIK 1134765HealthcareFiscal year ends Dec 31
Reports and events: 291 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1716:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-028182 |
| 2026-08-0417:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-025735 |
| 2026-06-0516:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-019751 |
| 2026-05-2118:34 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-017985 |
| 2026-05-2016:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017948 |
| 2026-04-2016:30 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001437749-26-012836 |
| 2026-04-0118:35 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-010761 |
| 2026-02-1317:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-26-004180 |
| 2025-11-1916:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-035731 |
| 2025-08-2107:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-027482 |
| 2025-08-1107:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-025812 |
| 2025-06-2716:36 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-021440 |
| 2025-06-2417:20 ET | DEF 14A | Proxy statementPeriod 2025-08-07 | 0001437749-25-021182 |
| 2025-06-0316:15 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-25-019288 |
| 2025-05-2916:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-018798 |
| 2025-04-1707:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-25-012214 |
| 2024-11-2706:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-24-036295 |
| 2024-11-1914:04 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-035717 |
| 2024-08-1915:45 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-027186 |
| 2024-06-2815:32 ET | 8-K | 4.01 Change of auditor; 5.07 Shareholder vote results | 0001437749-24-021549 |
| 2024-06-0306:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-24-018949 |
| 2024-05-2016:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-017669 |
| 2024-04-2913:00 ET | DEF 14A | Proxy statementPeriod 2024-06-26 | 0001437749-24-013594 |
| 2024-04-1916:31 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-24-012565 |
| 2024-04-1516:31 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-012061 |
| 2023-11-1416:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-031976 |
| 2023-08-1416:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-023663 |
| 2023-06-3010:54 ET | 8-K | 4.01 Change of auditor | 0001437749-23-018982 |
| 2023-06-2016:49 ET | 8-K | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-23-017870 |
| 2023-05-1906:02 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-015181 |
| 2023-04-2716:45 ET | DEF 14A | Proxy statement | 0001437749-23-011396 |
| 2023-04-1716:37 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001437749-23-010449 |
| 2023-04-0407:31 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-23-009173 |
| 2023-02-1016:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001851734-23-000052 |
| 2022-11-1806:07 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001851734-22-000695 |
| 2022-08-1216:22 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001851734-22-000443 |
| 2022-05-1616:21 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001851734-22-000268 |
| 2022-04-1216:17 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001851734-22-000194 |
| 2022-03-0312:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001851734-22-000130 |
| 2022-02-1810:21 ET | SC 13D/A | Ownership report, active investor, amended | 0001851734-22-000107 |
| 2021-11-1507:01 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001851734-21-000076 |
| 2021-11-0307:00 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001851734-21-000029 |
| 2021-08-1606:58 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001654954-21-008956 |
| 2021-06-1617:23 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-21-006972 |
| 2021-05-2817:26 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-21-006391 |
| 2021-05-2612:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001654954-21-006288 |
| 2021-05-1716:30 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001654954-21-005891 |
| 2021-05-1316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-21-005620 |
| 2021-04-0616:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-21-003894 |
| 2021-04-0521:03 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001654954-21-003838 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.